4thQ Earnings

Discussion in 'GlaxoSmithKline' started by anonymous, Feb 2, 2016 at 9:55 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Will there be positive earnings tomorrow sending the share price northward?
     

  2. anonymous

    anonymous Guest

    7am EST and the answer will be known. If we miss, then Phil Hampton will be getting out his broom.
     
  3. anonymous

    anonymous Guest

    Shares of Glaxo rose 0.5 percent to 1,432.50 pence as of 12:14 p.m. in London trading as sales for the quarter climbed 2 percent to 6.29 billion pounds, comparing with a 6.26 billion pound average estimate from analysts. Revenue from its blockbuster respiratory medicine Advair was 1.03 billion pounds, beating analysts’ estimate of 910.1 million pounds.

    GlaxoSmithKline Plc, the U.K.’s biggest drugmaker, posted fourth-quarter earnings that missed analysts’ estimates as sales of its pharmaceutical unit declined.

    Profit excluding certain costs dropped 23 percent to 1.36 billion pounds ($1.97 billion), the London-based company said in a statement on Wednesday. That missed the 1.47 billion pound average of nine analysts’ estimates compiled by Bloomberg. Core earnings per share of 18.1 pence matched the average of analyst estimates.
     
  4. anonymous

    anonymous Guest

    Profits dropped 23%. We'll, you've done a heck of a job, whittie.:eek:
     
  5. anonymous

    anonymous Guest

    A loss of $616 million for the 4th qtr. Everybody better update their resumes.
     
  6. anonymous

    anonymous Guest

    Is that why the stock went to $42 today?
     
  7. anonymous

    anonymous Guest

    major investors know there is new leadership on the horizon.... it's about time
     
  8. anonymous

    anonymous Guest

    4thQ Earnings can be described as "not good enough"

    Bye Bye Whitty
     
  9. anonymous

    anonymous Guest

    from outside.......soon !